The US Food and Drug Administration (FDA) has approved Eli Lilly’s Inluriyo (imlunestrant) to treat advanced or metastatic ...

Pharming Group has announced that the US Food and Drug Administration (FDA) has accepted its supplemental New Drug ...

Micheal Tague, President of Porterhouse Medical US, commented: “We are thrilled to welcome Jennifer to the team. Her ...

What constitutes a positive outcome for patients does not always align with the outcomes of interest to researchers’ ...

Medscape Education is proud to stand alongside the National Kidney Foundation (NKF) as a sponsor of one of the nation’s most ...

SAY Communications has selected Overcoming MS as the recipient of its annual pro bono programme, offering strategic and ...

Takeda Pharmaceuticals and Astex Pharmaceuticals are the latest companies to join the AI Structural Biology (AISB) Network, a ...

Johnson & Johnson has announced that the US Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for use in ...

For high-demand, comprehensive cases, systematic literature review (SLR) methodologies are indispensable.

The agreement enables US patients to access medicines at a discount, in addition to providing Pfizer with relief from US ...

Amgen has announced a $650m expansion of its US manufacturing network, focused on its Juncos, Puerto Rico site. The ...

A new report from the European Court of Auditors (ECA) has found that medicine shortages across the EU reached record levels ...